What is HC Wainwright’s Forecast for AnaptysBio Q1 Earnings?
AnaptysBio, Inc. (NASDAQ:ANAB – Free Report) – Research analysts at HC Wainwright dropped their Q1 2025 EPS estimates for AnaptysBio in a research report issued on Wednesday, February 12th. HC Wainwright analyst E. Bodnar now forecasts that the biotechnology company will post earnings per share of ($1.56) for the quarter, down from their prior forecast […]
